Categories: News

VERNAL CAPITAL ACQUISITION CORP. ANNOUNCES PRICING OF $100 MILLION INITIAL PUBLIC OFFERING

NEW YORK, May 6, 2026 /PRNewswire/ — Vernal Capital Acquisition Corp. (NYSE: VECA) (“Vernal”) announced the pricing of its initial public offering (the “IPO”) of 10,000,000 units at $10.00 per unit. The units are expected to trade on the New York Stock Exchange (“NYSE”) under “VECAU” beginning May 6, 2026. Each unit consists of one ordinary share and one right to receive one-fourth of one ordinary share upon consummation of an initial business combination. Upon separate trading, the ordinary shares and rights are expected to be listed on NYSE under “VECA” and “VECAR,” respectively.

- Advertisement -

D. Boral Capital LLC is acting as sole book-running manager of the offering. The underwriters have a 45-day option to purchase up to 1,500,000 additional units to cover any over-allotments. The offering is expected to close on May 7, 2026, subject to customary closing conditions.

- Advertisement -

A registration statement for these securities was declared effective by the SEC on May 5, 2026. The offering is made only by means of a prospectus. Copies of the prospectus may be obtained, from D. Boral Capital LLC, 590 Madison Ave., 39th Floor, New York, New York 10022, by telephone at (212) 970-5150 or by email at dbccapitalmarkets@dboralcapital.com.

- Advertisement -

This press release shall not constitute an offer to sell or to buy, nor shall there be any sale where such offer, solicitation or sale would be unlawful prior to registration or qualification under the applicable securities laws.

- Advertisement -

About Vernal

- Advertisement -

Vernal is a blank check company formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Vernal’s target search will not be limited to a particular industry or geographic region.

- Advertisement -

Forward-Looking Statements

- Advertisement -

This press release contains “forward-looking statements,” including statements regarding Vernal’s IPO. These statements are subject to risks and uncertainties that could cause actual results to differ materially. No assurance can be given that the offering will be completed on the terms described, or at all. Forward-looking statements are subject to numerous conditions, beyond Vernal’s control, including those in the Risk Factors section of Vernal’s registration statement filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. Vernal disclaims any obligation to release publicly updates or revisions to any forward-looking statements to reflect any change in Vernal’s expectations, except as required by law.

- Advertisement -

Contact

- Advertisement -

Binghan Yi, CFO
binghan@vernal.com
www.vernalspac.com

- Advertisement -

Logo – https://mma.prnewswire.com/media/2971353/Vernal_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/vernal-capital-acquisition-corp-announces-pricing-of-100-million-initial-public-offering-302763384.html

- Advertisement -

Recent Posts

JASIWAY Best-Selling Modern Sleeper Sofa Chair Launches on Wayfair, Bringing Flexible Small-Space Living to Modern American Homes

Sheridan, WY, July 04, 2026 (GLOBE NEWSWIRE) -- JASIWAY, a modern furniture brand focused on…

3 hours ago

iFLYTEK Officially Launches Open Platform in Central Asia, Positioning Uzbekistan as a New Regional AI Hub

TASHKENT, Uzbekistan, July 04, 2026 (GLOBE NEWSWIRE) -- Global artificial intelligence leader iFLYTEK officially launched iFLYTEK…

3 hours ago

Crypto News: AlphaPepe Reveals CEX Partnership With Biconomy As Ethereum Price Prediction Targets $7,000

MONACO , July 04, 2026 (GLOBE NEWSWIRE) -- Crypto news is turning toward AlphaPepe after…

3 hours ago

IPSEN – Buy-back programme – Art 5 of MAR – Week 26- 2026

 Aggregated presentation by day and by market Purchases of own shares from June 22nd to…

12 hours ago

Delta Clinics Reports Increase in Demand for Body Contouring Treatments

Delta Clinics notes evolving patient preferences toward comprehensive body contouring procedures, often combining multiple treatments…

12 hours ago

HEALBE’s Technology Powers SHARP’s First Health-Focused Smartwatch

SHARP Corporation integrates HEALBE's patented FLOW® technology into the Karada Mate Watch, enabling automatic calorie…

12 hours ago